Pharmafile Logo
Pharmafocus logo
Advanced Search

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON

October 21, 2025
Manufacturing and Production ImmunBiology, Infection Innovation Consortium, Recipharm, Vaccine, pneumococcal disease

Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based vaccine against pneumococcal disease, developed …

News

IMed Consultancy releases white paper on Digital Mental Health Technologies

October 20, 2025
Medical Communications Digital Mental Health Technologies, IMed Consultancy, MHRA

IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has published a new white paper …

News

Chemify relocates to Glasgow’s new Health Innovation Hub

October 17, 2025
Research and Development Chemify, Kadans Science Partner, Scotland

The company will be one of the first tenants in the city’s flagship life sciences facility

News

Oxford North UK innovation district officially opened

October 16, 2025
Research and Development Oxford North, University of Oxford, innovation district

Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …

News

Julius Clinical appoints Bassem Saleh as CEO

October 16, 2025
Julius Clinical, cardiometabolic diseases, central nervous system

Julius Clinical, a Netherlands-based clinical research organisation (CRO), has appointed Bassem Saleh as its new chief executive officer (CEO). Saleh …

Appointment
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation

October 14, 2025
Alto Neuroscience, FDA, schizophrenia

Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) has received Fast Track designation …

News

FairJourney Biologics appoints Dr Werner Lanthaler as CEO

October 14, 2025
FairJourney Biologics

FairJourney Biologics (FJBio), Portuguese antibody discovery and development company, has appointed Dr Werner Lanthaler as its new chief executive officer. …

Appointment
drug-trials

ANGLE unveils new strategy with executive reshuffle and name change to CelLBx Health

October 13, 2025
Business Services Angle

ANGLE has outlined a revised business strategy centred on tighter cost management, accelerated commercial execution, and long-term sustainability. The update …

News

Symeres appoints Gabriella Gentile as chief operating officer

October 13, 2025
Research and Development Symeres

Symeres, a mid-sized contract research, development and manufacturing organisation (CRDMO), has appointed Gabriella Gentile as its chief operating officer. Operating …

Appointment

Uterine fibroids and the cost of silence

October 9, 2025
Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …

Feature

Owen Mumford appoints Mark Glass as pharmaceutical services director

October 9, 2025
Owen Mumford

Owen Mumford, a developer and manufacturer of medical devices, has appointed Mark Glass as its new Director of Pharmaceutical Services. …

Appointment

Recipharm designates Germany site as Centre of Excellence

October 9, 2025
Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations

News
covid_cell

COVID-19 vaccine eligibility creates challenges for UK pharmacies

October 8, 2025
Medical Communications COVID-19, NHS, pharmacies, vaccinations

Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments despite no longer meeting the …

News

Celtic Renewables pushes for use of bio-based materials in pharma industry

October 8, 2025
Manufacturing and Production Celtic Renewables, Green Chemicals, sustainability

The company produces low-carbon, sustainable bio-based chemicals

News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025
Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours

News
drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

October 6, 2025
Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology

The agreement expands access to oncology testing kits across Europe

News

Novel excipients: the key to unlocking drug innovation

October 6, 2025
Business Services Lubrizol, Pharmacy

ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …

Feature
Thought Leadership

The Pharma Files: With Colin Williams from Astellas Pharma

October 5, 2025
Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …

Feature

How can optichannel engagement drive return on investment across the product life cycle?

October 3, 2025
Business Services, Consultancy Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement

HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …

Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025
Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026